NICE refuses to fund life-prolonging cancer drug available in Scotland
13th Nov 2006, 22:14 GMT
NICE has refused to fund a lung cancer drug which prolongs life even though it is already available in Scotland. The health watchdog's decision will stoke controversy over access to expensive modern cancer medicines
NICE refuses to fund life-prolonging cancer drug available in Scotland related news:
- NICE refuses to fund £20,000 cancer drug available in Scotland — the Mail online | Home
- NICE refuse to fund life-prolonging cancer drug available in Scotland — the Mail online | Health
- Cancer drug guidance concern — BBC News | Health | UK Edition
- Dismay over cancer drug guidance — BBC News | Latest Published Stories | UK Edition
- Cancer drug guidance dismay — BBC News | UK News | England | World Edition
- NICE disapproves the use of cancer drug Tarceva — The Earth Times Online Newspaper
- ENGLAND WON'T GET LUNG DRUG — Mirror.co.uk - 3am - 3am Content
- NICE rejects use of cancer drug Tarceva — Pharmaceutical Business Review Latest News
- MIT receives Ludwig Fund cancer grant — United Press International - NewsTrack
- Ludwig Fund donates $20 million to University of Chicago for cancer research — EurekAlert! - Chemistry, Physics and Materials Sciences
Latest news from the Mail online | Health:
- Designer twins are born healthy after screened for cystic fibrosis
- NICE refuse to fund life-prolonging cancer drug available in Scotland
- Dentist shortage leads man to superglue own tooth
- I was frozen to improve my health
- Why do I have dark circles under my eyes?
- Why smokers must have equal rights to health care
- Warning: Nurses at work
- I thought only women got osteoporosis - until my back exploded on the dance floor
- How you can snuff out the snuffles
- Robot that swims up your spine to take pictures of fractures